Difference between revisions of "Template:Lipid modifying agents"
Jump to navigation
Jump to search
imported>Anypodetos |
imported>Ronhjones (use listclass = hlist in navbox as per WP:HLIST) |
||
| Line 2: | Line 2: | ||
| name = Lipid modifying agents | | name = Lipid modifying agents | ||
| title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | | title = [[Hypolipidemic agent|Lipid modifying agents]] ([[ATC code C10|C10]]) | ||
| + | |listclass = hlist | ||
| groupstyle = background:MistyRose; | | groupstyle = background:MistyRose; | ||
| Line 9: | Line 10: | ||
| group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]] | | group1 = [[Cholesterol absorption inhibitor]]s, [[NPC1L1]] | ||
| − | | list1 = [[Ezetimibe]] | + | | list1 = |
| + | * [[Ezetimibe]] | ||
| + | * [[SCH-48461]] | ||
| group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]]) | | group2 = [[Bile acid sequestrant]]s/[[Ion exchange resin|resins]] ([[Low-density lipoprotein|LDL]]) | ||
| − | | list2 = [[Cholestyramine]] | + | | list2 = |
| + | * [[Cholestyramine]] | ||
| + | * [[Colestipol]] | ||
| + | * [[Colestilan]] | ||
| + | * [[Colextran]] | ||
| + | * [[Colesevelam]] | ||
}} | }} | ||
| Line 22: | Line 30: | ||
| group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]]) | | group1 = [[Statin]]s ([[HMG-CoA reductase]], [[Low-density lipoprotein|LDL]]) | ||
| − | | list1 = [[Simvastatin]]<sup>#</sup> | + | | list1 = |
| + | * [[Simvastatin]]<sup>#</sup> | ||
| + | * [[Atorvastatin]] | ||
| + | * [[Fluvastatin]] | ||
| + | * [[Lovastatin]] | ||
| + | * [[Mevastatin]] | ||
| + | * [[Pitavastatin]] | ||
| + | * [[Pravastatin]] | ||
| + | * [[Rosuvastatin]] | ||
| + | * [[Cerivastatin]]<sup>‡</sup> | ||
| group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]]) | | group2 = Niacin and derivatives ([[High-density lipoprotein|HDL]] and [[Low-density lipoprotein|LDL]]) | ||
| − | | list2 = [[Niceritrol]] | + | | list2 = |
| + | * [[Niceritrol]] | ||
| + | * [[Niacin]] | ||
| + | * [[Nicofuranose]] | ||
| + | * [[Aluminium nicotinate]] | ||
| + | * [[Nicotinyl alcohol]] | ||
| + | * [[Acipimox]] | ||
}} | }} | ||
| Line 34: | Line 57: | ||
| group1 = [[Fibrate]]s ([[PPAR modulator|PPAR]]) | | group1 = [[Fibrate]]s ([[PPAR modulator|PPAR]]) | ||
| − | | list1 = [[Clofibrate]]<sup>‡</sup> | + | | list1 = |
| + | * [[Clofibrate]]<sup>‡</sup> | ||
| + | * [[Bezafibrate]] | ||
| + | * [[Aluminium clofibrate]] | ||
| + | * [[Gemfibrozil]] | ||
| + | * [[Fenofibrate]] | ||
| + | * [[Simfibrate]] | ||
| + | * [[Ronifibrate]] | ||
| + | * [[Ciprofibrate]] | ||
| + | * [[Etofibrate]] | ||
| + | * [[Clofibride]] | ||
| + | * [[Clinofibrate]] | ||
| group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]]) | | group2 = [[CETP inhibitor]]s ([[High-density lipoprotein|HDL]]) | ||
| − | | list2 = [[Anacetrapib]]<sup>†</sup> | + | | list2 = |
| + | * [[Anacetrapib]]<sup>†</sup> | ||
| + | * [[Dalcetrapib]] | ||
| + | * [[Evacetrapib]] | ||
| + | * [[Torcetrapib]]<sup>§</sup> | ||
| Line 46: | Line 84: | ||
| group7 = Combinations | | group7 = Combinations | ||
| − | | list7 = [[Niacin/lovastatin]] | + | | list7 = |
| + | * [[Niacin/lovastatin]] | ||
| + | * [[Niacin/simvastatin]] | ||
| + | * [[Ezetimibe/simvastatin]] | ||
| + | * [[Laropiprant|Niacin/laropiprant]] | ||
| group8 = Other | | group8 = Other | ||
| − | | list8 = [[Dextrothyroxine]] | + | | list8 = |
| + | * [[Dextrothyroxine]] | ||
| + | * [[Probucol]] | ||
| + | * [[Tiadenol]] | ||
| + | * [[Benfluorex]] | ||
| + | * [[Meglutol]] | ||
| + | * [[Omega-3-triglycerides]] | ||
| + | * [[Magnesium pyridoxal 5-phosphate glutamate]] | ||
| + | * [[Policosanol]] | ||
| + | * [[Lapaquistat]]<sup>§</sup> | ||
| + | * [[Mipomersen]] | ||
| + | * [[Alipogene tiparvovec]] | ||
| list9 = {{PharmNavFootnote}} | | list9 = {{PharmNavFootnote}} | ||
| Line 58: | Line 111: | ||
}}<noinclude> | }}<noinclude> | ||
| − | [[Category:Drug_templates by ATC | + | [[Category:Drug_templates by ATC]] |
[[pt:Predefinição:Hipolipemiantes]] | [[pt:Predefinição:Hipolipemiantes]] | ||
</noinclude> | </noinclude> | ||